Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder | Azimova | Neurology, Neuropsychiatry, Psychosomatics

Neurology, Neuropsychiatry, Psychosomatics
Nevrologiâ, nejropsihiatriâ, psihosomatika

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)

eng | рус

Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Archives

Download this PDF file

For citations:

Azimova JE, Sivolap YP, Ishchenko KA. Clinical effectiveness and safety of prolonged release form of alimemazine in patients with generalized anxiety disorder. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2023;15(3):68-75. (In Russ.) https://doi.org/10.14412/2074-2711-2023-3-68-75

Views PDF (Rus): 804

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)

* not an advertisement

Indexing Databases

* not an advertisement

Popular articles

Editor-in-Chief

Parfenov V.A.

Article Tools

How to cite item

Email this article (Login required)

Email the author (Login required)

About the Authors

Ju. E. Azimova
Research Institute of General Pathology and Pathophysiology; LLC “University Headache Clinic”
Russian Federation

Julia Eduardovna Asimova

18, Baltiyskaya St., Moscow 125315; 2, Molodogvardeiskaya St., Build. 1, Moscow 121467

Yu. P. Sivolap
Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)
Russian Federation

Department of Psychiatry, Psychotherapy and Psychosomatic Pathology, Faculty of Continuing Medical Education.

6, Mikluho-Maklaya St., Moscow 117198

K. A. Ishchenko
JSC “Valenta Pharm”
Russian Federation

26, Ryabinovaya St., Build. 10, Moscow 121471

Notifications